Evidence that an active NADPH oxidase is required for NET formation has come from studies using inhibitors of the oxidase, knockout mice, or neutrophils from patients with chronic granulomatous disease (CGD) whose NADPH oxidase is non-functional (Stasia and Li, 2008). The gene discussed is FMO5; the disease is chronic granulomatous disease.